Lamivudine inhibits hepatitis B virus replication in kidney graft recipients [4]

Transplantation

Volumn 66, Issue 3, 1998, Pages 407-409

  Goffin, Eric ^a   Horsmans, Yves ^a   Cornu, Chantal ^a   Squifflet, Jean Paul ^a   Pirson, Yves ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; LAMIVUDINE;

ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GRAFT REJECTION; LETTER; PRIORITY JOURNAL; RECIPIENT; RECURRENT DISEASE; VIRUS REPLICATION;

EID: 0032529431     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199808150-00025     Document Type: Letter

References (11)

1. Fairley CK, Mijch A, Gust ID, Nichilson S, Dimitrakakis M, Lucas CR. The increased risk of fatal liver disease in renal transplant patients who are hepatitis B e antigen and/or HBV DNA positive. Transplantation 1991; 52: 497.
2. Magnone M, Holley JL, Shapiro R, et al. Interferon-α induced acute renal allograft rejection. Transplantation 1995; 59: 1068.
3. Rostaing L, Modesto A, Baron E, Cisterne JM, Chabannier MH, Durand D. Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C. Nephron 1996; 74: 512.
4. Rostaing L, Henry S, Cisterne JM, Duffaut M, Icart J, Durand D. Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation. Transplantation 1997; 64: 1624.
5. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333: 1657.
6. Benhamou Y, Dohin E, Lunel-Fabiani F, et al. Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients. Lancet 1995; 345: 396.
7. Grellier L, Mutimer D, Ahmed M, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 348: 1212.
8. Bain VG, Kneteman NM, Ma MM, et al. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation 1996; 62: 1456.
9. Ling R, Mutimer D, Ahmed M, et al. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 1996; 24: 711.
10. Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DLJ. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996; 24: 714.
11. Schalm SW. Clinical implications of lamivudine resistance by HBV. Lancet 1997; 349 : 3.